1
|
Bogani D, Siggers P, Brixey R, Warr N, Beddow S, Edwards J, Williams D, Wilhelm D, Koopman P, Flavell RA, Chi H, Ostrer H, Wells S, Cheeseman M, Greenfield A. Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. PLoS Biol 2009; 7:e1000196. [PMID: 19753101 PMCID: PMC2733150 DOI: 10.1371/journal.pbio.1000196] [Citation(s) in RCA: 122] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2009] [Accepted: 08/06/2009] [Indexed: 11/29/2022] Open
Abstract
Sex determination in mammals is controlled by the presence or absence of the Y-linked gene SRY. In the developing male (XY) gonad, sex-determining region of the Y (SRY) protein acts to up-regulate expression of the related gene, SOX9, a transcriptional regulator that in turn initiates a downstream pathway of testis development, whilst also suppressing ovary development. Despite the requirement for a number of transcription factors and secreted signalling molecules in sex determination, intracellular signalling components functioning in this process have not been defined. Here we report a role for the phylogenetically ancient mitogen-activated protein kinase (MAPK) signalling pathway in mouse sex determination. Using a forward genetic screen, we identified the recessive boygirl (byg) mutation. On the C57BL/6J background, embryos homozygous for byg exhibit consistent XY gonadal sex reversal. The byg mutation is an A to T transversion causing a premature stop codon in the gene encoding MAP3K4 (also known as MEKK4), a mitogen-activated protein kinase kinase kinase. Analysis of XY byg/byg gonads at 11.5 d post coitum reveals a growth deficit and a failure to support mesonephric cell migration, both early cellular processes normally associated with testis development. Expression analysis of mutant XY gonads at the same stage also reveals a dramatic reduction in Sox9 and, crucially, Sry at the transcript and protein levels. Moreover, we describe experiments showing the presence of activated MKK4, a direct target of MAP3K4, and activated p38 in the coelomic region of the XY gonad at 11.5 d post coitum, establishing a link between MAPK signalling in proliferating gonadal somatic cells and regulation of Sry expression. Finally, we provide evidence that haploinsufficiency for Map3k4 accounts for T-associated sex reversal (Tas). These data demonstrate that MAP3K4-dependent signalling events are required for normal expression of Sry during testis development, and create a novel entry point into the molecular and cellular mechanisms underlying sex determination in mice and disorders of sexual development in humans.
Collapse
Affiliation(s)
- Debora Bogani
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Pam Siggers
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Rachel Brixey
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Nick Warr
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Sarah Beddow
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Jessica Edwards
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Debbie Williams
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Dagmar Wilhelm
- The Institute of Molecular Bioscience, University of Queensland, Brisbane, Australia
| | - Peter Koopman
- The Institute of Molecular Bioscience, University of Queensland, Brisbane, Australia
| | - Richard A. Flavell
- Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America
| | - Hongbo Chi
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
| | - Harry Ostrer
- Human Genetics Program, New York University School of Medicine, New York, New York, United States of America
| | - Sara Wells
- The Mary Lyon Centre, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Michael Cheeseman
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
- The Mary Lyon Centre, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| | - Andy Greenfield
- Mammalian Genetics Unit, Medical Research Council (MRC) Harwell, Oxfordshire, United Kingdom
| |
Collapse
|
2
|
Jawaheer D, Juo SHH, Le Caignec C, David A, Petit C, Gregersen P, Dowbak S, Damle A, McElreavey K, Ostrer H. Mapping a gene for 46,XY gonadal dysgenesis by linkage analysis. Clin Genet 2003; 63:530-5. [PMID: 12786760 DOI: 10.1034/j.1399-0004.2003.00082.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
46,XY gonadal dysgenesis was transmitted as an autosomal-dominant trait in a large family with multiple affected members. Expressivity of the trait was highly variable, ranging from pure to partial gonadal dysgenesis associated with normal female genitalia or sexual ambiguity, to mild hypospadias in otherwise normal males. The phenotypic features of this trait appeared to be confined to the genitourinary system. Multipoint parametric analysis using markers D5S664, D5S633, and D5D2102 yielded an LOD score of 4.47, assuming sex-limited, autosomal-dominant inheritance with a penetrance of 0.6. Because mutation in testis-determining genes leads to gonadal dysgenesis in 46,XY individuals, we postulate that the gene mapped by this study normally plays a role in gonadal differentiation.
Collapse
Affiliation(s)
- D Jawaheer
- Division of Biology and Human Genetics, North Shore University Hospital, Manhasset, New York, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Abstract
Genetic studies in familial cases of sex reversal and in human embryos have contributed to the understanding of human sex determination and its disorders. For some heritable disorders of sex reversal, the gonadal phenotype was frequently overlooked until sex reversal was discovered fortuitously by chromosome analysis, often resulting in preventable complications. Within families, the phenotypes are variable and, in some instances, these can be explained by known genetic mechanisms. When a novel molecular marker is shared by family members affected with sex reversal, the level of confidence is higher that this marker may play a role in the development of the phenotype. The identification of pedigrees with sufficient power to generate significant linkage of disorder (lod) scores from genomewide screens can now lead to the identification of novel sex-determining genes. Studies of the gonads of 46,XY human embryos have shown that SOX9 expression follows a pattern similar to that of SRY and, in both instances, stands in contrast to the expression observed in the mouse. Differences between human and mouse embryonic gonads have also been observed for the temporal expression of DAX1, suggesting that the mechanisms of action of SRY, SOX9, and DAX1 may vary between these and other species.
Collapse
Affiliation(s)
- H Ostrer
- Human Genetics Program, Department of Pediatrics, New York University School of Medicine, New York, NY 10016, USA.
| |
Collapse
|